Newsroom | 5794 results

CHICAGO--(BUSINESS WIRE)--ClostraBio, a biotechnology company developing next-generation probiotics to support gut health, joined fellow winners of the Chicago Innovation Awards, the Chicago region’s foremost annual celebration of innovation, in New York City on Monday, August 31st to ring the Opening Nasdaq Bell. The event emphasized the breadth of innovation in the Chicago region and shined a spotlight on the organizations that make up its vibrant economy. “Chicago Innovation Award winners cu...

PORTLAND, Ore.--(BUSINESS WIRE)--Whitney Economics (WE), a global leader in cannabis and hemp business consulting, data, and economic research, today announced it has released a U.S. hemp cannabinoid report for 2026. Data provided by hemp operators in 35 states indicate a profitable, growing industry that is adapting to expanding state regulations. At $38.7 billion in Total Addressable Market (TAM) value, with an estimated 350,000 jobs earning $13.9 billion in wages, the hemp-cannabinoid sector...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today the topline 52-week results (Part C) from its Phase 3 COMP005 trial of COMP360, a synthetic, proprietary formulation of psilocybin, for treatment-resistant depression (TRD) which further support COMP360’s differentiated profile and potential for long lasting benefit. The open-label Part C data demonst...

ROANOKE, Va.--(BUSINESS WIRE)--Foot Levelers, today announced its first-ever ‘Founder’s Edition’ event being held at its headquarters October 24-25, 2026 featuring Dr. Ronald Oberstein and Dr. Brian Jensen. Foot Levelers, the global standard and world’s leading provider of custom stabilizing orthotics, is hosting its famous PracticeXcelerator program with the option to include Continuing Education Units and offering a rare “behind-the-scenes tour” of the Foot Levelers manufacturing facility in...

BASKING RIDGE, N.J.--(BUSINESS WIRE)--IVI RMA North America, a leader in fertility care and assisted reproduction, announced today that Dr. Blake Vessa, a reproductive endocrinologist and infertility specialist, has joined the RMA New Jersey care team. Dr. Vessa is now seeing patients at RMA Basking Ridge, IVI RMA’s flagship clinic, located at 140 Allen Road. “We are thrilled to welcome Dr. Vessa to the RMA NJ team as her extensive training, strong commitment to research and education, and dedi...

ATHLONE, Irland--(BUSINESS WIRE)--Dunbar Pharmaceuticals („Dunbar Pharma” oder „das Unternehmen”) , Irlands erster EU-GMP-zertifizierter Hersteller von pflanzlichen Cannabinoid-Wirkstoffen (APIs), gab heute bekannt, dass er an der expopharm 2026 vom 15. bis 17. September 2026 in München auf dem Messegelände der Messe München, Am Messesee 2, 81829 München, Deutschland teilnehmen wird. Die expopharm, eine der führenden europäischen Fachmessen für den Apothekenmarkt, bringt Apotheker, Pharmauntern...

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced a broadening of its medical cannabis portfolio in Australia across its Spectrum Therapeutics, Spectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands. The expansion introduces two new product formats, and new formulations within its existing oil and softgel ranges....

ATHLONE, Ireland--(BUSINESS WIRE)--Dunbar Pharmaceuticals will be attending expopharm 2026 in Munich from 15–17 September 2026....

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”) today announced the closing of its acquisition of 100% of the outstanding equity interests in PharmaCann Penn, LLC (“PharmaCann”) for an aggregate consideration of US$50 million (the “Transaction”). The Transaction consists of nine operational retail medical marijuana dispensaries in Pennsylvania, advancing Cresco’s leadership position in the second-largest medical marijuana market, wh...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences and events: Stifel Hosted Webinar: Definium Therapeutics Virtual Fireside Chat Presentation Date and Time: T...